CDKN2A and melanoma: Moreover, through exome sequencing, previously reported melanoma onco- and tumor suppressor- genes have been confirmed (BRAF, NRAS, CDKN2A, TP53, and PTEN), and several additional mutated melanoma genes have been identified (MAP2K1, IDH1, RB1, and DDX3X).